The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,907.00
Bid: 1,906.00
Ask: 1,908.00
Change: -25.00 (-1.29%)
Spread: 2.00 (0.105%)
Open: 1,926.00
High: 1,926.00
Low: 1,907.00
Prev. Close: 1,932.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Glencore leads fallers early on

Wed, 29th Aug 2012 08:25

- Spain a concern as Catalonia needs aid- Markets await Bernanke- Ex-div Glencore a heavy faller early onEx-div stocks and miners were weighing heavily on the FTSE 100 index in early trading on Wednesday morning with worries about Spain weighing on sentiment.It was revealed yesterday that the recession in Spain was deeper than first thought in the second quarter, with concerns intensifying after reports that the regional government of Catalonia would be requesting around €5bn from Spain's liquidity fund."Catalonia also seems stubborn on political conditions relating to the emergency funds, causing some anxiety for potential future lenders to Spain as a whole. This is pretty big news for the Eurozone as any seemed resistance to conditions relating to any emergency funds could cause a pretty big headache down the line," said trader Simon Furlong from Spreadex.Economists at FxPro said in an e-mailed note this morning that investors are now waiting for Ben Bernanke for a lift: "As the Chairman of the US Federal Reserve gets up to speak on Friday, his words will determine whether markets are imbued with hope or despair ahead of the next US monetary policy meeting in September."FTSE 100: Ex-div stocks, miners down early onEx-dividend stocks were providing a drag this morning, including heavyweights Croda International, Glencore, Legal & General and Xstrata.Nevertheless, Glencore and Xstrata were being pressured lower by reports that Xstrata shareholder Norges Bank Investment Management has raised its stake in the miner in the last few weeks. The Norwegian fund is expected to join forces with Qatari Holdings to vote to block the merger between the two groups.Copper producer Antofagasta was also lower despite beating EPS estimates in the first half as a decrease in copper prices was offset by higher levels of production.Outsourcing group Serco was higher after saying that it expects good growth in full-year organic revenues in 2012 despite a 2.1% fall in the first half.FTSE 250: RusPetro drops after swinging into the redWest Siberia-focused oil and gas firm RusPetro was a heavy faller in the opening hour after reporting a pre-tax loss of $26.4m, compared with a profit of $0.6m in the first half of last year. Revenues, however, tripled as production ramps up.UK and Continental property investment firm Hansteen gained after reporting a sharp rise in half-year profit despite adverse currency movement. On a like-for-like basis, occupancy, values and rent all improved.A host of second-tier stocks went ex-dividend today and were trading in the red, such as African Barrick Gold, Devro, Ferrexpo, Henderson, Hikma, Hochschild Mining, Lancashire Holdings, Rotork, Wood Group, Micro Focus, Rank Group and Stagecoach.FTSE 100 - RisersSSE (SSE) 1,373.00p +1.18%Serco Group (SRP) 567.00p +0.80%Hargreaves Lansdown (HL.) 616.00p +0.65%Centrica (CNA) 328.90p +0.40%Reed Elsevier (REL) 580.00p +0.35%Pennon Group (PNN) 740.50p +0.27%WPP (WPP) 838.00p +0.18%Hammerson (HMSO) 451.60p +0.18%Admiral Group (ADM) 1,179.00p +0.17%Standard Chartered (STAN) 1,419.00p +0.11%FTSE 100 - FallersGlencore International (GLEN) 368.50p -4.04%Eurasian Natural Resources Corp. (ENRC) 310.70p -2.48%Rio Tinto (RIO) 2,793.00p -2.41%Xstrata (XTA) 918.00p -2.26%Legal & General Group (LGEN) 128.00p -1.99%Aviva (AV.) 321.00p -1.86%International Consolidated Airlines Group SA (CDI) (IAG) 142.40p -1.73%Anglo American (AAL) 1,834.50p -1.66%Vedanta Resources (VED) 889.00p -1.66%BHP Billiton (BLT) 1,905.50p -1.40%FTSE 250 - RisersSt James's Place (STJ) 346.99p +3.21%SVG Capital (SVI) 279.90p +3.13%Chemring Group (CHG) 332.60p +2.65%Homeserve (HSV) 216.50p +1.88%Kier Group (KIE) 1,320.00p +1.85%Galliford Try (GFRD) 632.00p +1.69%Perform Group (PER) 380.00p +1.55%Brewin Dolphin Holdings (BRW) 146.80p +1.52%Spirent Communications (SPT) 156.70p +1.42%ITE Group (ITE) 203.10p +1.30%FTSE 250 - FallersRuspetro (RPO) 130.60p -7.70%Redrow (RDW) 137.80p -4.90%Kentz Corporation Ltd. (KENZ) 369.40p -3.02%Dunelm Group (DNLM) 587.50p -2.81%Micro Focus International (MCRO) 544.50p -2.77%Henderson Group (HGG) 104.80p -2.69%Ted Baker (TED) 991.50p -2.51%Rank Group (RNK) 137.03p -2.47%New World Resources A Shares (NWR) 288.80p -2.43%Centamin (DI) (CEY) 77.30p -2.28%BC
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.